SurvivorNet on MSN
How genetic testing company Tempus AI is using data and artificial intelligence to help personalize cancer care
How Genetic Testing Company Tempus AI Is Using Data and Artificial Intelligence to Help Personalize Cancer Care ...
NewYork-Presbyterian's program offers self-referred genetic testing, focusing on personalized cancer prevention and care.
The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage ...
For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...
For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...
Next-generation sequencing is widely regarded as a transformative technology that delivers potentially life-prolonging therapies to patients with advanced cancers. Yet the testing is still underused ...
Patient-centered education and navigation support increase consent rates for genomic testing, aiding integration into cancer care and access to genomics-based trials. The SURGE study underscores the ...
Cancer treatment is becoming more personalized. By considering a patient's unique genetic and molecular profile, along with their lifestyle and environmental factors, doctors can make more accurate ...
Kassiane Saieed explains how genomic tools provide data to help patients personalize their breast cancer treatment and survivorship. For many premenopausal women diagnosed with breast cancer, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results